Apollon Wealth Management, LLC - BRIACELL THERAPEUTICS CORP ownership

BRIACELL THERAPEUTICS CORP's ticker is BCTX and the CUSIP is 10778Y302. A total of 27 filers reported holding BRIACELL THERAPEUTICS CORP in Q3 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.3%.

Quarter-by-quarter ownership
Apollon Wealth Management, LLC ownership history of BRIACELL THERAPEUTICS CORP
ValueSharesWeighting
Q3 2022$101,000
+9.8%
17,900
+12.6%
0.01%0.0%
Q2 2022$92,000
-34.8%
15,900
+14.4%
0.01%
-20.0%
Q1 2022$141,000
-25.8%
13,900
-39.3%
0.01%
-28.6%
Q4 2021$190,000
+21.0%
22,900
+18.0%
0.01%
-36.4%
Q3 2021$157,00019,4000.02%
Other shareholders
BRIACELL THERAPEUTICS CORP shareholders Q3 2022
NameSharesValueWeighting ↓
Redmond Asset Management, LLC 136,593$1,106,0000.35%
Total Clarity Wealth Management, Inc. 11,425$93,0000.04%
Virtu Financial LLC 32,952$267,0000.02%
Apollon Wealth Management, LLC 19,400$157,0000.02%
Summit Trail Advisors, LLC 35,000$284,0000.02%
FNY Investment Advisers, LLC 4,687$37,0000.02%
Freedom Investment Management, Inc. 16,649$135,0000.01%
VOLORIDGE INVESTMENT MANAGEMENT, LLC 156,946$1,271,0000.01%
Belvedere Trading LLC 13,608$107,0000.00%
GOFEN & GLOSSBERG LLC /IL/ 10,000$81,0000.00%
View complete list of BRIACELL THERAPEUTICS CORP shareholders